In Patients with Heart Failure Who Take SGLT-2 Inhibitors: Do Mineralocorticoid Receptor Antagonists Alter Effectiveness?

NEJM Journal Watch（2021）

引用 0|浏览0

暂无评分

摘要

Sodium–glucose cotransporter-2 (SGLT-2) inhibitors have emerged as efficacious therapies that decrease adverse outcomes in patients with heart failure

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要